These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 25432390)
21. Lipoprotein(a) in Atherosclerotic Diseases: From Pathophysiology to Diagnosis and Treatment. Lampsas S; Xenou M; Oikonomou E; Pantelidis P; Lysandrou A; Sarantos S; Goliopoulou A; Kalogeras K; Tsigkou V; Kalpis A; Paschou SA; Theofilis P; Vavuranakis M; Tousoulis D; Siasos G Molecules; 2023 Jan; 28(3):. PubMed ID: 36770634 [TBL] [Abstract][Full Text] [Related]
22. When should we measure lipoprotein (a)? Kostner KM; März W; Kostner GM Eur Heart J; 2013 Nov; 34(42):3268-76. PubMed ID: 23735860 [TBL] [Abstract][Full Text] [Related]
23. The journey towards understanding lipoprotein(a) and cardiovascular disease risk: are we there yet? Boffa MB; Koschinsky ML Curr Opin Lipidol; 2018 Jun; 29(3):259-267. PubMed ID: 29528858 [TBL] [Abstract][Full Text] [Related]
24. Lipoprotein(a) and its role in inflammation, atherosclerosis and malignancies. Orsó E; Schmitz G Clin Res Cardiol Suppl; 2017 Mar; 12(Suppl 1):31-37. PubMed ID: 28188431 [TBL] [Abstract][Full Text] [Related]
25. [Lipoprotein(a): a link between thrombosis and atherosclerosis?]. Hansen PR Ugeskr Laeger; 1993 May; 155(20):1527-30. PubMed ID: 8316983 [TBL] [Abstract][Full Text] [Related]
26. [Lipoprotein(a) as a cardiovascular risk factor]. van Lennep JE; Mulder MT Ned Tijdschr Geneeskd; 2011; 155(42):A3582. PubMed ID: 22027461 [TBL] [Abstract][Full Text] [Related]
29. Genetics and metabolism of lipoprotein(a) and their clinical implications (Part 1). Dieplinger H; Kronenberg F Wien Klin Wochenschr; 1999 Jan; 111(1):5-20. PubMed ID: 10067265 [TBL] [Abstract][Full Text] [Related]
30. Apheresis in coronary heart disease with elevated Lp (a): a review of Lp (a) as a risk factor and its management. Keller C Ther Apher Dial; 2007 Feb; 11(1):2-8. PubMed ID: 17309568 [TBL] [Abstract][Full Text] [Related]
31. [Determination of lipoproteins defined following their apolipoprotein composition for the prediction of cardiovascular risk]. Duriez P; Fruchart JC Ann Biol Clin (Paris); 1994; 52(3):179-83. PubMed ID: 7998673 [TBL] [Abstract][Full Text] [Related]
36. [The Role of Lipoprotein(a) in the Development of Peripheral and Carotid Atherosclerosis]. Tmoyan NA; Afanasieva OI; Ezhov MV Kardiologiia; 2018 Jun; 58(6):70-78. PubMed ID: 30362439 [TBL] [Abstract][Full Text] [Related]
37. Lipoprotein(a) in health and disease. Kronenberg F; Steinmetz A; Kostner GM; Dieplinger H Crit Rev Clin Lab Sci; 1996; 33(6):495-543. PubMed ID: 8989507 [TBL] [Abstract][Full Text] [Related]
38. Plasma lipoprotein(a) concentration predicts future coronary and cardiovascular events in patients with stable coronary heart disease. Nestel PJ; Barnes EH; Tonkin AM; Simes J; Fournier M; White HD; Colquhoun DM; Blankenberg S; Sullivan DR Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2902-8. PubMed ID: 24092750 [TBL] [Abstract][Full Text] [Related]
39. Lipoprotein(a): Its relevance to the pediatric population. McNeal CJ J Clin Lipidol; 2015; 9(5 Suppl):S57-66. PubMed ID: 26343213 [TBL] [Abstract][Full Text] [Related]
40. The renaissance of lipoprotein(a): Brave new world for preventive cardiology? Ellis KL; Boffa MB; Sahebkar A; Koschinsky ML; Watts GF Prog Lipid Res; 2017 Oct; 68():57-82. PubMed ID: 28888913 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]